Baidu
map

使用来氟米特后血压升高?这个问题一定要重视!

2022-11-10 问问风湿APP 问问风湿APP

来氟米特片属于改善病情类抗风湿药,目前在临床上用于成人的风湿性关节炎或者是狼疮性的肾炎的治疗,目前在国内临床使用已有近20年的时间,缓解了许多风湿病患者的痛苦,疗效确切,服用方便。

来氟米特片属于改善病情类抗风湿药,目前在临床上用于成人的风湿性关节炎或者是狼疮性的肾炎的治疗,目前在国内临床使用已有近20年的时间,缓解了许多风湿病患者的痛苦,疗效确切,服用方便。

在治疗类风湿性关节炎的过程中,来氟米特片疗效确切,安全性好,可以显著地改善患者关节功能活动,而且可以有效地阻止破骨细胞的分化,同时抑制骨关节的破坏,达到保护关节的作用。但有些患者在服用一段时间后,发现自己出现了血压增高的现象,这是怎么回事呢?其实来氟米特可能会引起血压增高这件事,在药物说明书中是明确提到过的,但是因为很多患者日常并不会对血压进行监测,同时因为高血压的症状在身体表现上并不是很明显,所以大家对其引起的血压上升问题也并不是很重视。但随着风湿患者心脑血管疾病患病率的升高,越来越多的患者开始重视血压的稳定,同时也开始了解到了来氟米特的这类特性。那么我们今天就简单聊一聊,如何正确应对来氟米特带来的血压升高的问题。

高血压是一种常见病和多发病。此病一般起病缓慢,早期常无症状,或仅有头晕、 头痛、心悸、耳鸣等症状,表面上看是一种独立的疾病,实际上是引发心、脑血管和肾病变的一个重要的危险因素,如果治疗不当就会病变成为较严重的脑中风、心肌梗死和肾功能衰竭等这些常见高血压并发症,严重影响健康甚至生命。

1、出现血压升高的时间为服药后1周至1年,多为半年以内。

2、收缩压和舒张压均明显上升。

3、多数患者血压升高,却无头昏、头痛等任何不适感。

4、大多数患者口服降压药无效,必须停服来氟米特后血压方可渐降至正常。

1、在服用来氟米特前后,一定要密切监测血压变化。

2、出现血压增高后,来氟米特服用减量(需咨询医生)。

3、如果有高血压史,可在原来降压药的基础上,加用其它降压药。

4、及时调整药物,可改用其它免疫制剂如甲氨蝶呤、硫酸羟氯喹等等。

在没有高血压史的情况下,如果停用来氟米特或改用其他药物后仍然血压高,就可能是风湿病本身的原因。

希腊学者调查研究发现,风湿性疾病患者共病高血压很常见,622例患者中,高血压患病率达到54.5% ,其中骨关节炎、类风湿关节炎和银屑病关节炎患者的高血压患病率最高,分别为69.6%、60.9%、57.8%。

在高血压患者中,21.7%的人不知道高血压水平,67.2%的人接受了治疗。只有48.6%的高血压患者达到了2018年ESC/ESH治疗目标。

因此如果出现血压增高的现象,需要综合考虑多种因素,在医生的建议下调整用药治疗方案。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2099771, encodeId=91792099e71c0, content=提请心血管大夫及患者注意,属于药物性高血压, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5281475204, createdName=delianjihui, createdTime=Fri Nov 11 00:11:00 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099770, encodeId=c8112099e70e7, content=转发学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5281475204, createdName=delianjihui, createdTime=Fri Nov 11 00:10:27 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099769, encodeId=aead2099e6992, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5281475204, createdName=delianjihui, createdTime=Fri Nov 11 00:10:15 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099768, encodeId=0b8d2099e68ec, content=学习受益, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5281475204, createdName=delianjihui, createdTime=Fri Nov 11 00:10:10 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099450, encodeId=69932099450ca, content=签到学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43718258358, createdName=ms3000002106324246, createdTime=Wed Nov 09 19:06:32 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099426, encodeId=9fe9209942617, content=不错,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65aa5643711, createdName=小白努力长高高, createdTime=Wed Nov 09 17:48:53 CST 2022, time=2022-11-09, status=1, ipAttribution=)]
    2022-11-11 delianjihui

    提请心血管大夫及患者注意,属于药物性高血压

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2099771, encodeId=91792099e71c0, content=提请心血管大夫及患者注意,属于药物性高血压, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5281475204, createdName=delianjihui, createdTime=Fri Nov 11 00:11:00 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099770, encodeId=c8112099e70e7, content=转发学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5281475204, createdName=delianjihui, createdTime=Fri Nov 11 00:10:27 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099769, encodeId=aead2099e6992, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5281475204, createdName=delianjihui, createdTime=Fri Nov 11 00:10:15 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099768, encodeId=0b8d2099e68ec, content=学习受益, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5281475204, createdName=delianjihui, createdTime=Fri Nov 11 00:10:10 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099450, encodeId=69932099450ca, content=签到学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43718258358, createdName=ms3000002106324246, createdTime=Wed Nov 09 19:06:32 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099426, encodeId=9fe9209942617, content=不错,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65aa5643711, createdName=小白努力长高高, createdTime=Wed Nov 09 17:48:53 CST 2022, time=2022-11-09, status=1, ipAttribution=)]
    2022-11-11 delianjihui

    转发学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2099771, encodeId=91792099e71c0, content=提请心血管大夫及患者注意,属于药物性高血压, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5281475204, createdName=delianjihui, createdTime=Fri Nov 11 00:11:00 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099770, encodeId=c8112099e70e7, content=转发学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5281475204, createdName=delianjihui, createdTime=Fri Nov 11 00:10:27 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099769, encodeId=aead2099e6992, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5281475204, createdName=delianjihui, createdTime=Fri Nov 11 00:10:15 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099768, encodeId=0b8d2099e68ec, content=学习受益, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5281475204, createdName=delianjihui, createdTime=Fri Nov 11 00:10:10 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099450, encodeId=69932099450ca, content=签到学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43718258358, createdName=ms3000002106324246, createdTime=Wed Nov 09 19:06:32 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099426, encodeId=9fe9209942617, content=不错,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65aa5643711, createdName=小白努力长高高, createdTime=Wed Nov 09 17:48:53 CST 2022, time=2022-11-09, status=1, ipAttribution=)]
    2022-11-11 delianjihui

    感谢分享

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2099771, encodeId=91792099e71c0, content=提请心血管大夫及患者注意,属于药物性高血压, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5281475204, createdName=delianjihui, createdTime=Fri Nov 11 00:11:00 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099770, encodeId=c8112099e70e7, content=转发学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5281475204, createdName=delianjihui, createdTime=Fri Nov 11 00:10:27 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099769, encodeId=aead2099e6992, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5281475204, createdName=delianjihui, createdTime=Fri Nov 11 00:10:15 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099768, encodeId=0b8d2099e68ec, content=学习受益, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5281475204, createdName=delianjihui, createdTime=Fri Nov 11 00:10:10 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099450, encodeId=69932099450ca, content=签到学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43718258358, createdName=ms3000002106324246, createdTime=Wed Nov 09 19:06:32 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099426, encodeId=9fe9209942617, content=不错,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65aa5643711, createdName=小白努力长高高, createdTime=Wed Nov 09 17:48:53 CST 2022, time=2022-11-09, status=1, ipAttribution=)]
    2022-11-11 delianjihui

    学习受益

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2099771, encodeId=91792099e71c0, content=提请心血管大夫及患者注意,属于药物性高血压, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5281475204, createdName=delianjihui, createdTime=Fri Nov 11 00:11:00 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099770, encodeId=c8112099e70e7, content=转发学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5281475204, createdName=delianjihui, createdTime=Fri Nov 11 00:10:27 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099769, encodeId=aead2099e6992, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5281475204, createdName=delianjihui, createdTime=Fri Nov 11 00:10:15 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099768, encodeId=0b8d2099e68ec, content=学习受益, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5281475204, createdName=delianjihui, createdTime=Fri Nov 11 00:10:10 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099450, encodeId=69932099450ca, content=签到学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43718258358, createdName=ms3000002106324246, createdTime=Wed Nov 09 19:06:32 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099426, encodeId=9fe9209942617, content=不错,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65aa5643711, createdName=小白努力长高高, createdTime=Wed Nov 09 17:48:53 CST 2022, time=2022-11-09, status=1, ipAttribution=)]
    2022-11-09 ms3000002106324246

    签到学习

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2099771, encodeId=91792099e71c0, content=提请心血管大夫及患者注意,属于药物性高血压, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5281475204, createdName=delianjihui, createdTime=Fri Nov 11 00:11:00 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099770, encodeId=c8112099e70e7, content=转发学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5281475204, createdName=delianjihui, createdTime=Fri Nov 11 00:10:27 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099769, encodeId=aead2099e6992, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5281475204, createdName=delianjihui, createdTime=Fri Nov 11 00:10:15 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099768, encodeId=0b8d2099e68ec, content=学习受益, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5281475204, createdName=delianjihui, createdTime=Fri Nov 11 00:10:10 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099450, encodeId=69932099450ca, content=签到学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43718258358, createdName=ms3000002106324246, createdTime=Wed Nov 09 19:06:32 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099426, encodeId=9fe9209942617, content=不错,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65aa5643711, createdName=小白努力长高高, createdTime=Wed Nov 09 17:48:53 CST 2022, time=2022-11-09, status=1, ipAttribution=)]
    2022-11-09 小白努力长高高

    不错,谢谢分享

    0

相关资讯

全国大降温,血压却升高?高血压患者面对重重风险,当如何应对

近日,冷空气杀了一个回马枪,全国多个省市气温骤降,北京甚至飘起了雪,感觉整个人都是冰冰的。

Hypertension:血压升高的年轻人存在亚临床收缩和舒张功能障碍

血压和脂肪量是左心室收缩和舒张功能的具有统计学显著性的决定因素。即使在低于目前定义的高血压范围的BP水平,也可以检测到左心室收缩和舒张功能的亚临床变化。

Hypertension:儿童期或青少年期血压升高与成年时心血管疾病结局

总之,该系统评价和荟萃分析证实,儿童或青少年BP升高与成年时心血管疾病的一些中间指标和直接结局有关。这些发现强调了维持儿童和青少年血压正常的重要性。

JAMA Netw Open:主动或被动吸烟,均可导致儿童和青少年的血压升高!

随着社会经济的发展和居民生活方式的改变,高血压已成为影响我国乃至全球居民健康的重大公共卫生问题之一。近40年来,以南非洲国家,南亚国家和一些太平洋岛国等中低收入国家高血压人数增幅最大,其中,2.26亿

Ann Intern Med:见医生血压高,可能是有病!6万余人数据表明,白大褂高血压与全因死亡风险上升33%,心血管疾病死亡风险上升109%有关

对于去医院这种事,好多人是纯天然地打心眼儿里排斥。小朋友见到医生就要哭闹,成年人闻到医院的消毒水味儿也要觉得浑身不自在。

Hypertension:急诊科血压升高是心血管事件的危险因素

由此可见,ED测量的BP提供了重要且未被充分利用的工具,其具有降低与高血压相关的发病率和死亡率的巨大潜力。

Baidu
map
Baidu
map
Baidu
map